Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1307361 | 1.00 | LMNA (0.57) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL12112857 | 1.00 | LMNA (0.57) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL12112859 | 0.85 | LMNA (0.59) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL1307670 | 0.85 | LMNA (0.59) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL1307672 | 0.85 | LMNA (0.59) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL16326401 | 0.81 | LMNA (0.75) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL8232803 | 0.78 | LMNA (0.81) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL7642884 | 0.77 | LMNA (0.69) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL1305952 | 0.77 | SMN1; SMN2 (0.44) | LMNAKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL12112861 | 0.77 | SMN1; SMN2 (0.44) | LMNAKMT2AMEN1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8053590-B2 | Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-11-08 | — | — | US | disclosed |
| US-20090203918-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2009-08-13 | — | — | US | disclosed |
| US-7514578-B2 | Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2009-04-07 | — | — | US | disclosed |
| EP-1778627-B1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2, 3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-02-27 | — | — | EP | disclosed |
| US-20070238778-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-10-11 | — | — | US | disclosed |
| EP-1778627-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2, 3-DIAMINOPROPIONIC ACID DERIVATIVES | Sanofi-Aventis Deutschland GmbH (DE) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006005436-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2, 3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203918-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | DDC, ADM2, MTHFD2 | LMNA 4330/4885KMT2A 2002/4885MEN1 715/4885 |
| US-20070238778-A1 | METHOD FOR PRODUCING ENANTIOMERIC FORM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | DDC, DAO, ADM2 | LMNA 4437/4885KMT2A 1462/4885MEN1 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.